Vanguard Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $117M | Buy |
13,010,001
+1,965,181
| +18% | +$27.1M | ﹤0.01% | 1812 |
|
|
2025
Q3 | $191M | Buy |
11,044,820
+192,651
| +2% | +$2.37M | ﹤0.01% | 1560 |
|
|
2025
Q2 | $102M | Buy |
10,852,169
+100,138
| +0.9% | +$822K | ﹤0.01% | 1825 |
|
|
2025
Q1 | $76.4M | Buy |
10,752,031
+561,978
| +6% | +$5.68M | ﹤0.01% | 1909 |
|
|
2024
Q4 | $119M | Buy |
10,190,053
+562,249
| +6% | +$8.77M | ﹤0.01% | 1794 |
|
|
2024
Q3 | $198M | Buy |
9,627,804
+527,736
| +6% | +$12.2M | ﹤0.01% | 1548 |
|
|
2024
Q2 | $204M | Buy |
9,100,068
+6,356
| +0.1% | +$151K | ﹤0.01% | 1486 |
|
|
2024
Q1 | $250M | Buy |
9,093,712
+746,263
| +9% | +$20.7M | 0.01% | 1377 |
|
|
2023
Q4 | $255M | Buy |
8,347,449
+155,579
| +2% | +$4.47M | 0.01% | 1368 |
|
|
2023
Q3 | $259M | Buy |
8,191,870
+6,719
| +0.1% | +$261K | 0.01% | 1299 |
|
|
2023
Q2 | $334M | Buy |
8,185,151
+52,373
| +0.6% | +$2.12M | 0.01% | 1176 |
|
|
2023
Q1 | $303M | Buy |
8,132,778
+322,552
| +4% | +$12.7M | 0.01% | 1199 |
|
|
2022
Q4 | $272M | Buy |
7,810,226
+1,192,903
| +18% | +$56.7M | 0.01% | 1248 |
|
|
2022
Q3 | $370M | Buy |
6,617,323
+108,041
| +2% | +$6.7M | 0.01% | 1015 |
|
|
2022
Q2 | $337M | Buy |
6,509,282
+117,342
| +2% | +$5.96M | 0.01% | 1102 |
|
|
2022
Q1 | $465M | Sell |
6,391,940
-50,415
| -0.8% | -$4.27M | 0.01% | 1020 |
|
|
2021
Q4 | $762M | Buy |
6,442,355
+89,021
| +1% | +$11.2M | 0.02% | 770 |
|
|
2021
Q3 | $852M | Buy |
6,353,334
+327,157
| +5% | +$49.5M | 0.02% | 707 |
|
|
2021
Q2 | $976M | Buy |
6,026,177
+447,433
| +8% | +$34.8M | 0.02% | 670 |
|
|
2021
Q1 | $448M | Buy |
5,578,744
+447,547
| +9% | +$30M | 0.01% | 1027 |
|
|
2020
Q4 | $279M | Buy |
5,131,197
+754,398
| +17% | +$27.4M | 0.01% | 1252 |
|
|
2020
Q3 | $87M | Buy |
4,376,799
+119,603
| +3% | +$2.49M | ﹤0.01% | 1753 |
|
|
2020
Q2 | $89.5M | Buy |
4,257,196
+768,947
| +22% | +$13.1M | ﹤0.01% | 1733 |
|
|
2020
Q1 | $42.7M | Sell |
3,488,249
-35,950
| -1% | -$484K | ﹤0.01% | 1943 |
|
|
2019
Q4 | $51.7M | Buy |
3,524,199
+71,738
| +2% | +$998K | ﹤0.01% | 2092 |
|
|
2019
Q3 | $46.1M | Buy |
3,452,461
+268,345
| +8% | +$4.28M | ﹤0.01% | 2110 |
|
|
2019
Q2 | $52.1M | Buy |
3,184,116
+371,724
| +13% | +$5.84M | ﹤0.01% | 2075 |
|
|
2019
Q1 | $48M | Buy |
2,812,392
+66,266
| +2% | +$988K | ﹤0.01% | 2104 |
|
|
2018
Q4 | $37.5M | Buy |
2,746,126
+92,961
| +4% | +$1.73M | ﹤0.01% | 2156 |
|
|
2018
Q3 | $75.9M | Buy |
2,653,165
+287,682
| +12% | +$8.37M | ﹤0.01% | 1936 |
|
|
2018
Q2 | $64.7M | Buy |
2,365,483
+355,970
| +18% | +$8.62M | ﹤0.01% | 1993 |
|
|
2018
Q1 | $42.4M | Buy |
2,009,513
+173,032
| +9% | +$4.26M | ﹤0.01% | 2158 |
|
|
2017
Q4 | $35.3M | Buy |
1,836,481
+791,188
| +76% | +$18.3M | ﹤0.01% | 2238 |
|
|
2017
Q3 | $26M | Buy |
1,045,293
+48,005
| +5% | +$904K | ﹤0.01% | 2366 |
|
|
2017
Q2 | $16M | Buy |
997,288
+92,580
| +10% | +$1.29M | ﹤0.01% | 2558 |
|
|
2017
Q1 | $12.7M | Buy |
904,708
+33,925
| +4% | +$455K | ﹤0.01% | 2645 |
|
|
2016
Q4 | $11.4M | Buy |
870,783
+431,153
| +98% | +$6.48M | ﹤0.01% | 2689 |
|
|
2016
Q3 | $7.48M | Buy |
439,630
+23,066
| +6% | +$446K | ﹤0.01% | 2813 |
|
|
2016
Q2 | $8.89M | Buy |
+416,564
| New | +$11.1M | ﹤0.01% | 2707 |
|
Other funds holding NTLA
AIM
RP
